ALKEM

Alkem Laboratories Share PriceAlkem Laboratories

₹4,647.9
-75.65 (-1.6%)
  • Advice
  • Hold
As on 04 December, 2023 | 02:54 BSE: 539523 NSE: ALKEMISIN: INE540L01014

Alkem Laboratories Performance

Day Range

  • Low 4,621.75
  • High 4,741.95
₹ 4,647.9

52 Week Range

  • Low 2,940.05
  • High 4,795.50
₹ 4,647.9
  • Open Price4,724.90
  • Previous Close4,723.55
  • Volume264101

Start SIP in Alkem Laboratories

Start SIP

Alkem Laboratories Share Price

  • Over 1 Month 24.85%
  • Over 3 Month 28.58%
  • Over 6 Month 37.5%
  • Over 1 Year 48.49%

Alkem Laboratories Key Statistics

P/E Ratio 38.8
PEG Ratio 1.2
Market Cap Cr 55,573
Price to Book Ratio 5.9
EPS 95.7
Dividend 1.1
Relative Strength Index 77.8
Money Flow Index 82.69
MACD Signal 210.17
Average True Range 98.82

Alkem Laboratories Investment Rating

  • Master Rating:
  • Alkem Laboratories has an operating revenue of Rs. 12,351.40 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 11% is healthy, ROE of 10% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 19% and 29% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 9% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 70 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Alkem Laboratories Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 2,6352,2532,2382,2972,4612,0582,006
Operating Expenses Qtr Cr 1,9801,9191,9061,8412,0561,8751,807
Operating Profit Qtr Cr 655334332456406183200
Depreciation Qtr Cr 59585758585755
Interest Qtr Cr 19212223202213
Tax Qtr Cr -84775475120109
Net Profit Qtr Cr 64727125538935114077
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 9,3219,030
Operating Expenses Annual Cr 7,6787,019
Operating Profit Annual in Cr 1,3771,810
Depreciation Cr 230219
Interest Annual Cr 8638
Tax Annual Cr 193212
Net Profit Annual Cr 1,1341,541
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 1,299
Cash from Investing Activity Annual Cr -1,669
Cash from Financing Annual Activity Cr 437
Net Cash Flow Annual Cr 67
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 9,3508,744
Fixed Assets Annual Cr 2,0542,115
Total Non Current Assets Annual Cr 5,9596,309
Total Current Assets Annual Cr 6,7726,861
Total Assets Annual Cr 12,73113,169
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 782731
ROE Annual % 1218
ROCE Annual % 1520
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1823
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 3,4402,9682,9033,0413,0792,5762,484
Operating Expenses Qtr Cr 2,6932,5792,5492,4422,6252,3732,147
Operating Profit Qtr Cr 747389353599454203337
Depreciation Qtr Cr 74727878777683
Interest Qtr Cr 30302927252717
Tax Qtr Cr 3365144795520134
Net Profit Qtr Cr 62128771455331128108
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 11,81510,797
Operating Expenses Annual Cr 9,9908,581
Operating Profit Annual in Cr 1,6092,053
Depreciation Cr 310304
Interest Annual Cr 10752
Tax Annual Cr 298164
Net Profit Annual Cr 9841,646
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 1,111
Cash from Investing Activity Annual Cr -1,435
Cash from Financing Annual Activity Cr 380
Net Cash Flow Annual Cr 55
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 9,0458,638
Fixed Assets Annual Cr 2,5932,838
Total Non Current Assets Annual Cr 5,0275,634
Total Current Assets Annual Cr 8,7308,435
Total Assets Annual Cr 13,75714,069
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 789740
ROE Annual % 1119
ROCE Annual % 1521
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1621

Alkem Laboratories Technicals

EMA & SMA

Current Price
₹4,647.9
-75.65 (-1.6%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹4,362.54
  • 50 Day
  • ₹4,064.23
  • 100 Day
  • ₹3,863.55
  • 200 Day
  • ₹3,662.56
  • 20 Day
  • ₹4,361.78
  • 50 Day
  • ₹3,903.23
  • 100 Day
  • ₹3,838.44
  • 200 Day
  • ₹3,587.72

Alkem Laboratories Resistance and Support

PIVOT
₹4,670.54
Resistance
First Resistance 4,719.32
Second Resistance 4,790.73
Third Resistance 4,839.52
RSI 77.80
MFI 82.69
MACD Single Line 210.17
MACD 221.02
Support
First Resistance 4,599.12
Second Resistance 4,550.33
Third Resistance 4,478.92

Alkem Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 274,692 19,555,323 71.19
Week 302,606 19,327,461 63.87
1 Month 332,132 16,237,929 48.89
6 Month 211,450 12,240,842 57.89

Alkem Laboratories Result Highlights

Alkem Laboratories Synopsis

NSE-Medical-Diversified

Alkem Laboratories is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 9054.55 Cr. and Equity Capital is Rs. 23.91 Cr. for the Year ended 31/03/2023. Alkem Laboratories Ltd. is a Public Limited Listed company incorporated on 08/08/1973 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L00305MH1973PLC174201 and registration number is 174201.
Market Cap 55,573
Sales 9,422
Shares in Float 5.14
No of funds 242
Yield 0.54
Book Value 5.94
U/D Vol ratio 2
LTDebt / Equity
Alpha 0.14
Beta 0.57

Alkem Laboratories

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 56.74%57.16%57.16%57.16%
Mutual Funds 13.05%11.45%10.19%10.06%
Insurance Companies 3.49%3.98%6%5.87%
Foreign Portfolio Investors 6.03%5.63%4.44%4.41%
Financial Institutions/ Banks
Individual Investors 19.36%20.61%21.43%21.73%
Others 1.33%1.17%0.78%0.77%

Alkem Laboratories Management

Name Designation
Mr. Basudeo N Singh Executive Chairman
Mr. Sandeep Singh Managing Director
Mrs. Madhurima Singh Executive Director
Mr. Balmiki Prasad Singh Executive Director
Mr. Mritunjay Kumar Singh Executive Director
Mr. Sarvesh Singh Executive Director
Mr. Arun Kumar Purwar Independent Director
Ms. Sangeeta Singh Independent Director
Ms. Sudha Ravi Independent Director
Dr. Dheeraj Sharma Independent Director
Mr. Narendra Kumar Aneja Independent Director
Mr. Sujjain Suresh Talwar Independent Director

Alkem Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Alkem Laboratories Corporate Action

Date Purpose Remarks
2023-11-07 Quarterly Results
2023-08-10 Quarterly Results
2023-05-19 Audited Results & Final Dividend
2023-02-10 Quarterly Results & Interim Dividend
2022-11-11 Quarterly Results
Date Purpose Remarks
2023-08-10 FINAL Rs.10.00 per share(500%)Final Dividend
2023-02-18 INTERIM Rs.15.00 per share(750%)Interim Dividend
2023-02-18 SPECIAL Rs.25.00 per share(1250%)Special Dividend
2022-08-10 FINAL Rs.4.00 per share(200%)Final Dividend
2022-02-12 INTERIM Rs.30.00 per share(1500%)Interim Dividend

Alkem Laboratories MF Shareholding

Name Amount(cr)
ICICI Prudential Bluechip Fund Growth 41,269
Kotak Emerging Equity Scheme Growth 33,700
ICICI Prudential Value Discovery Fund Growth 32,494
Kotak Equity Arbitrage Fund Growth 28,958
ICICI Prudential Equity & Debt Fund Growth 26,183

Alkem Laboratories FAQs

What is Share Price of Alkem Laboratories ?

Alkem Laboratories share price is ₹4,647 As on 04 December, 2023 | 02:40

What is the Market Cap of Alkem Laboratories ?

The Market Cap of Alkem Laboratories is ₹55572.6 Cr As on 04 December, 2023 | 02:40

What is the P/E ratio of Alkem Laboratories ?

The P/E ratio of Alkem Laboratories is 38.8 As on 04 December, 2023 | 02:40

What is the PB ratio of Alkem Laboratories ?

The PB ratio of Alkem Laboratories is 5.9 As on 04 December, 2023 | 02:40

Q2FY23